Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
Non-Standard Finance plc is listed on the main market of the London Stock Exchange (ticker: NSF) and was established in 2014 to acquire and grow businesses in the UK's non-standard consumer finance sector. Under the direction of its highly experienced main board, the Company has acquired a sustainable group of businesses offering credit to the c.10-12 million UK adults who are not served by (or choose not to use) mainstream financial institutions. Its three business divisions are: unsecured branch-based lending, guarantor loans and home credit. Each division is fully authorised by the FCA and has benefited from significant investment in branch expansion, recruitment, training and new IT infrastructure and systems. These investments have supported the delivery of improved customer outcomes together with growing financial returns for shareholders.
Highlands Natural Resources’ strategy is to develop a portfolio of projects whereby approximately 80% of projects generate secure and sustainable revenue while the other projects demonstrate the potential for exciting capital appreciation. This strategic objective is well advanced and we are generating revenue.
(Interview starts at 8 minutes 4 seconds)
“Dev Clever is a bespoke software development company established in 2014. We have quickly grown into a credible, recognised digital innovation brand, and have a multitude of blue-chip clients and educators across the UK and Europe. Our proprietary software and applications have been successfully delivered across multiple sectors, and Dev Clever has received industry accolades and awards for our use of innovative, interactive and immersive technologies. We have defined 3 channels for our products and services, Engage, Educate, Experience. You’ll see that with endless ideas and a unique approach to technology, we have the ability to evolve any business.”
(Interview starts at 16 minutes 12 seconds)
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
SP Angel research note on commodities and miners, featuring: Ferro-Alloy Resources Limited (FAR LN) – Fall in vanadium pentoxide price prompts management to look for new funding Resolute Mining (RSG LN) – Bibiani review Sirius Minerals (SXX LN) – A Siriusly sorry Christmas Carol Vast Resources* (VAST LN) 0.29p, Mkt Cap £29m – Exposure to copper and rough diamonds in Romania and Zimbabwe
Colin Bird Executive Chairman of Xtract Resources (XTR) talks about the Alluvial Collaboration Agreement with Nexus and provides a general update Russ Mould, Investment Director at stockbroker AJ Bell talks about: the Election Result, Macro and UK stocks Alan Green talks about 4 stocks
Mammoth Biosciences is a US-based biotech company that developed the world's first CRISPR-based detection platform capable of sensing any biomarker or disease with DNA/RNA backed by investors that include Mayfield, NFX, 8VC, AME Cloud, Wireframe, Kairos, along with Tim Cook, Brook Byers, Bob Nelsen, and Jeff Huber.
“It has given us substantial financial flexibility at a highly competitive rate of interest in the last three years as we have successfully carried out our multi-well Niger drilling campaign and completed the Seven Energy transaction."
Tim McCarthy, Chairman of ImmuPharma (IMM) discusses the deal with US-based Avion Pharmaceuticals, the agreement with Lanstead Capital and what the future holds for ImmuPharma regarding new trial design as well as anticipated upcoming milestones.
The hedge fund owned by the billionaire investor and anti-Brexit donor George Soros has made a £16m bet against shares in the owner of the Daily Mail newspaper, Ocado has said its product range will be 50% bigger and offer lower prices and better quality products when it switches from Waitrose to Marks & Spencer next year,
SPAngel research note on commodities and miners, featuring: Base Resources (BSE LN) – Toliara DFS confirms PFS estimates Premier African Minerals* (PREM LN) – Fundraising Resolute Mining (RSG LN) – Drilling results from Tabakoroni